Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

Also called NCT02080299

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
University Hospital, Essen (from the registry)
Registry
  • NCT NCT02080299
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02080299. Randomized; single masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2017-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Protection by Remote Ischemic Preconditioning During Transcatheter Aortic Valve Implantation
Condition
Aortic Valve Stenosis
Intervention (Procedure)
Remote ischemic preconditioning (RIPC)
Intervention (Procedure)
Placebo
Lead sponsor
University Hospital, Essen (class: other)
Collaborator
Koblenz University of Applied Science (class: other)

Record details

Record id
cardio:ct-nct02080299
Content hash
8ef27e9acbc80a0d781d850db00527d6ae39a9a15c2aabfc9959a49c326f27c7